These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10680053)

  • 41. Mechanisms of atherosclerosis: role of LDL oxidation.
    Reaven PD
    Adv Exp Med Biol; 1994; 366():113-28. PubMed ID: 7771247
    [No Abstract]   [Full Text] [Related]  

  • 42. Antioxidant and anti-atherogenic activities of three Piper species on atherogenic diet fed hamsters.
    Agbor GA; Vinson JA; Sortino J; Johnson R
    Exp Toxicol Pathol; 2012 May; 64(4):387-91. PubMed ID: 21035316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase.
    Kaplan M; Aviram M
    Clin Chem Lab Med; 1999 Aug; 37(8):777-87. PubMed ID: 10536926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dietary supplementation with beta-carotene, but not with lycopene, inhibits endothelial cell-mediated oxidation of low-density lipoprotein.
    Dugas TR; Morel DW; Harrison EH
    Free Radic Biol Med; 1999 May; 26(9-10):1238-44. PubMed ID: 10381195
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
    Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
    Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
    Aviram M
    Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coronary artery disease--free radical damage, antioxidant protection and the role of homocysteine.
    Maxwell SR
    Basic Res Cardiol; 2000; 95 Suppl 1():I65-71. PubMed ID: 11192356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of ionol on the development of experimental atherosclerosis].
    Deviatkina TA
    Dokl Akad Nauk SSSR; 1978; 242(2):449-52. PubMed ID: 213244
    [No Abstract]   [Full Text] [Related]  

  • 49. Relationships among oxidation of low-density lipoprotein, antioxidant protection, and atherosclerosis.
    Esterbauer H; Schmidt R; Hayn M
    Adv Pharmacol; 1997; 38():425-56. PubMed ID: 8895819
    [No Abstract]   [Full Text] [Related]  

  • 50. Prevention of atherosclerosis. The potential role of antioxidants.
    Mehra MR; Lavie CJ; Ventura HO; Milani RV
    Postgrad Med; 1995 Jul; 98(1):175-6, 179-84. PubMed ID: 7603945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antioxidants in the prevention of atherosclerosis.
    Olsson AG; Yuan XM
    Curr Opin Lipidol; 1996 Dec; 7(6):374-80. PubMed ID: 9117141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dietary polyunsaturated fat modifies low-density lipoproteins and reduces atherosclerosis of nonhuman primates with high and low diet responsiveness.
    Rudel LL; Johnson FL; Sawyer JK; Wilson MS; Parks JS
    Am J Clin Nutr; 1995 Aug; 62(2):463S-470S. PubMed ID: 7625361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antioxidants: the good, the bad and the ugly.
    Tardif JC
    Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):61B-65B. PubMed ID: 16498514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LDL heterogeneity and atherosclerosis in nonhuman primates.
    Rudel LL; Bond MG; Bullock BC
    Ann N Y Acad Sci; 1985; 454():248-53. PubMed ID: 3865611
    [No Abstract]   [Full Text] [Related]  

  • 55. Antioxidants and atherosclerosis: a current assessment.
    Chisolm GM
    Clin Cardiol; 1991 Feb; 14(2 Suppl 1):I25-30. PubMed ID: 2044256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. beta-Carotene and alpha-tocopherol inhibit the development of atherosclerotic lesions in hypercholesterolemic rabbits.
    Sun J; Giraud DW; Moxley RA; Driskell JA
    Int J Vitam Nutr Res; 1997; 67(3):155-63. PubMed ID: 9202975
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement.
    Upston JM; Terentis AC; Stocker R
    FASEB J; 1999 Jun; 13(9):977-94. PubMed ID: 10336881
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased oxidation resistance of atherogenic plasma lipoproteins at high vitamin E levels in non-vitamin E supplemented men.
    Porkkala-Sarataho E; Nyyssönen K; Salonen JT
    Atherosclerosis; 1996 Jul; 124(1):83-94. PubMed ID: 8800496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits.
    Yamakoshi J; Kataoka S; Koga T; Ariga T
    Atherosclerosis; 1999 Jan; 142(1):139-49. PubMed ID: 9920515
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LDL oxidation: therapeutic perspectives.
    Heller FR; Descamps O; Hondekijn JC
    Atherosclerosis; 1998 Apr; 137 Suppl():S25-31. PubMed ID: 9694538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.